- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03188874
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
April 17, 2024 updated by: Technische Universität Dresden
This is a registry study in adult patients with newly diagnosed or refractory/relapsed acute myeloid leukemia.
Investigator's sites: 51 sites in Germany.
Primary objectives:
- Identification of epidemiological data on AML: age, prognostic factors and subgroup distributions. Incidence and age distribution are compared with the data of population-related tumor registry.
- Evaluation of the most important patient-relevant clinical endpoints (outcomes): relapse-free survival (RFS) / time to relapse (TTR), calculation of cumulative incidence of relapse (CIR) and overall survival (OS)
- Documentation of treatment strategy
Study Overview
Status
Recruiting
Conditions
Detailed Description
see brief summary
Study Type
Observational
Enrollment (Estimated)
15000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christoph Röllig, Prof. Dr.
- Email: christoph.roellig@uniklinikum-dresden.de
Study Locations
-
-
-
Berlin, Germany, 13125
- Recruiting
- HELIOS Klinikum Berlin-Buch
-
Contact:
- Bertram Glaß, Prof.
-
Bremen, Germany, 28239
- Recruiting
- Ev. Diakonie-Krankenhaus gemeinn. GmbH Bremen
-
Contact:
- Ulrich Trappe, Prof. Dr.
-
-
Baden-Württemberg
-
Baden-Baden, Baden-Württemberg, Germany, 76532
- Recruiting
- Klinikum Mittelbaden
-
Contact:
- Kai Neben, Prof.
-
Heidelberg, Baden-Württemberg, Germany, 69120
- Recruiting
- Universtitätsklinikum Heidelberg
-
Contact:
- Carsten Müller-Tidow, Prof.
-
Mannheim, Baden-Württemberg, Germany, 68167
- Recruiting
- Klinikum Mannheim GmbH
-
Contact:
- Stefan Klein, PD Dr.
-
Schwäbisch Hall, Baden-Württemberg, Germany, 74523
- Recruiting
- Diakonie-Klinikum
-
Contact:
- Thomas Geer, Dr.
-
Sindelfingen, Baden-Württemberg, Germany, 71065
- Recruiting
- Kliniken Sindelfingen-Böblingen gGmbH
-
Contact:
- Markus Ritter, PD Dr.
-
Stuttgart, Baden-Württemberg, Germany, 70376
- Recruiting
- Robert-Bosch-Krankenhaus GmbH
-
Contact:
- Martin Kaufmann, Dr.
-
Winnenden, Baden-Württemberg, Germany, 71364
- Recruiting
- Rems-Murr-Klinikum Winnenden
-
Contact:
- Markus Schaich, Prof.
-
-
Bayern
-
Augsburg, Bayern, Germany, 86156
- Recruiting
- Klinikum Augsburg
-
Contact:
- Andreas Rank, PD Dr.
-
Bamberg, Bayern, Germany, 96049
- Recruiting
- Sozialstiftung Bamberg
-
Contact:
- Ruth Seggewiß-Bernhard, PD Dr.
-
Bayreuth, Bayern, Germany, 95445
- Recruiting
- Klinikum Bayreuth GmbH
-
Contact:
- Alexander Kiani, Prof.
-
Coburg, Bayern, Germany, 96450
- Recruiting
- MVZ Klinikum Coburg GmbH
-
Contact:
- Christof Lamberti, PD. Dr.
-
Erlangen, Bayern, Germany, 91054
- Recruiting
- Universitätsklinikum Erlangen
-
Contact:
- Stefan Krause, Prof.
-
Nürnberg, Bayern, Germany, 90419
- Recruiting
- Klinikum Nürnberg
-
Contact:
- Kerstin Schäfer-Eckart, Dr.
-
Würzburg, Bayern, Germany, 97080
- Recruiting
- Universitätsklinikum Würzburg
-
Contact:
- Hermann Einsele, Prof.
-
-
Brandenburg
-
Cottbus, Brandenburg, Germany, 03048
- Recruiting
- Carl-Thiem-Klinikum Cottbus gGmbH
-
Contact:
- Martin Schmidt-Hieber, PD Dr.
-
Frankfurt an der Oder, Brandenburg, Germany, 15236
- Recruiting
- Klinikum Frankfurt (Oder) GmbH
-
Contact:
- Michael Kiehl, Prof.
-
-
Hessen
-
Frankfurt am Main, Hessen, Germany, 60590
- Recruiting
- Universitatsklinikum Frankfurt
-
Contact:
- Hubert Serve, Prof.
-
Fulda, Hessen, Germany, 36043
- Recruiting
- Klinikum Fulda / MVZ Osthessen GmbH
-
Contact:
- Heinz-Gert Höffkes, Prof.
-
Marburg, Hessen, Germany, 35033
- Recruiting
- Universitätsklinikum Gießen und Marburg
-
Contact:
- Andreas Neubauer, Prof.
-
Wiesbaden, Hessen, Germany, 65199
- Recruiting
- Dr. Horst Schmidt Kliniken GmbH
-
Contact:
- Natalia Heinz, Dr.
-
-
Mecklenburg-Vorpommern
-
Neubrandenburg, Mecklenburg-Vorpommern, Germany, 17036
- Recruiting
- Diakonie Klinikum Dietrich Bonhoeffer
-
Contact:
- Philipp Hemmati, PD Dr.
-
Rostock, Mecklenburg-Vorpommern, Germany, 18059
- Recruiting
- Klinikum Südstadt Rostock
-
Contact:
- Beate Krammer-Steiner, Dr.
-
-
Niedersachsen
-
Hildesheim, Niedersachsen, Germany, 31134
- Recruiting
- St. Bernward Krankenhaus Hildesheim
-
Contact:
- Ulrich Kaiser, Prof.
-
Rotenburg, Niedersachsen, Germany, 27956
- Recruiting
- Agaplesion Diakonieklinikum Rotenburg
-
Contact:
- Achim Meinhardt, Dr.
-
-
Nordhein-Westfalen
-
Siegen, Nordhein-Westfalen, Germany, 57072
- Recruiting
- Marien Kliniken, St. Marien-Krankenhaus
-
Contact:
- Winfried Gassmann, Prof. Dr.
-
-
Nordrhein Westfalen
-
Düren, Nordrhein Westfalen, Germany, 52351
- Recruiting
- Krankenhaus Düren gGmbH
-
Contact:
- Michael Flaßhove, PD Dr.
-
-
Nordrhein-Westfalen
-
Aachen, Nordrhein-Westfalen, Germany, 52074
- Recruiting
- Universitätsklinikum Aachen
-
Contact:
- Tim H. Brümmendorf, Prof.
-
Bielefeld, Nordrhein-Westfalen, Germany, 33604
- Recruiting
- Städt. Kliniken Bielefeld gem. GmbH - Klinikum Mitte
-
Contact:
- Martin Görner, PD Dr.
-
Bochum, Nordrhein-Westfalen, Germany, 44791
- Recruiting
- Augusta Kranken Anstalt Bochum
-
Contact:
- Dirk Behringer, Prof.
-
Duisburg, Nordrhein-Westfalen, Germany, 47166
- Recruiting
- Helios Klinikum Duisburg
-
Contact:
- Götz Ulrich Grigoleit, PD Dr.
-
Düsseldorf, Nordrhein-Westfalen, Germany, 40225
- Recruiting
- Universitätsklinikum Düsseldorf
-
Contact:
- Paul Jäger, Dr.
-
Essen, Nordrhein-Westfalen, Germany, 45747
- Recruiting
- Universitätsklinikum Essen
-
Contact:
- Maher Hanoun, Dr.
-
Gütersloh, Nordrhein-Westfalen, Germany, 33332
- Recruiting
- Klinikum Gütersloh
-
Contact:
- Gero Massenkeil, Prof.
-
Hamm, Nordrhein-Westfalen, Germany, 59075
- Recruiting
- St. Barbara-Klinik Hamm GmbH
-
Contact:
- Heinz Dürk, Dr.
-
Münster, Nordrhein-Westfalen, Germany, 48149
- Recruiting
- Universitatsklinikum Munster
-
Contact:
- Wolfgang Berdel, Prof.
-
Siegen, Nordrhein-Westfalen, Germany, 57074
- Recruiting
- Diakonie Klinikum GmbH Jung-Stilling-Krankenhaus
-
Contact:
- Ralph Naumann, Prof. Dr.
-
Contact:
- Martin Klump, Dr.
-
-
Rheinland-Pfalz
-
Koblenz, Rheinland-Pfalz, Germany, 56068
- Recruiting
- Stiftungsklinikum Mittelrhein GmbH
-
Contact:
- Dirk Niemann, Dr.
-
-
Sachsen
-
Chemnitz, Sachsen, Germany, 09113
- Recruiting
- Klinikum Chemnitz gGmbH
-
Contact:
- Mathias Hänel, PD Dr.
-
Dresden, Sachsen, Germany, 01307
- Recruiting
- Universitätsklinikum Carl Gustav Carus
-
Contact:
- Christoph Röllig, Prof.
-
Leipzig, Sachsen, Germany, 04103
- Recruiting
- Universitatsklinikum Leipzig
-
Contact:
- Madlen Jentzsch, PD Dr.
-
Leipzig, Sachsen, Germany, 04129
- Recruiting
- Klinikum St. Georg gGmbH
-
Contact:
- Luisa Mantovani-Löffler, Dr.
-
Riesa, Sachsen, Germany, 01589
- Recruiting
- Elblandkliniken Stiftung & Co.KG
-
Contact:
- Jörg Schubert, Prof.
-
-
Sachsen-Anhalt
-
Halle (Saale), Sachsen-Anhalt, Germany, 06120
- Recruiting
- Universitatsklinikum Halle (Saale)
-
Contact:
- Lutz Peter Müller, Prof.
-
Halle (Saale), Sachsen-Anhalt, Germany, 06120
- Recruiting
- Krankenhaus Martha-Maria Halle-Dölau
-
Contact:
- Wolfgang Schütte, Prof.
-
Stendal, Sachsen-Anhalt, Germany, 39576
- Recruiting
- Johanniter-Krankenhaus Genthin-Stendal
-
Contact:
- Martin Mohren, PD Dr.
-
-
Schleswig-Holstein
-
Kiel, Schleswig-Holstein, Germany, 24105
- Recruiting
- Universitätsklinikum Schleswig-Holstein
-
Contact:
- Claudia Baldus, Prof.
-
Kiel, Schleswig-Holstein, Germany, 24116
- Recruiting
- Städtisches Krankenhaus Kiel GmbH
-
Contact:
- Roland Repp, Prof.
-
-
Thüringen
-
Altenburg, Thüringen, Germany, 04600
- Recruiting
- Klinikum Altenburger Land GmbH
-
Contact:
- Romy Pomper, Dr.
-
Jena, Thüringen, Germany, 07740
- Recruiting
- Universitätsklinikum Jena
-
Contact:
- Andreas Hochhaus, Prof.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with newly-diagnosed AML, including acute promyelocytic leukemia (APL)
Description
Inclusion Criteria:
- AML according to the WHO (World Health Organization) diagnostic criteria, including acute promyelocytic leukemia
- Age ≥ 18 years. There is no upper age limit.
- Signed written informed consent
Exclusion Criteria:
- there are no exclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Epidemiological parameters
Time Frame: 10 years
|
Epidemiological parameters
|
10 years
|
Relapse free survival (RFS)
Time Frame: 10 years
|
Relapse free survival
|
10 years
|
Time to relapse (TTR),
Time Frame: 10 years
|
Time to relapse (TTR),
|
10 years
|
Overall Survival (OS)
Time Frame: 10 years
|
Overall Survival (OS)
|
10 years
|
cumulative incidence of relapse (CIR)
Time Frame: 10 years
|
cumulative incidence of relapse (CIR)
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complete Remission (CR)
Time Frame: yearly follow up 10 years
|
Complete Remission
|
yearly follow up 10 years
|
Treatment related mortality (TRM)
Time Frame: yearly follow up 10 years
|
Treatment related mortality
|
yearly follow up 10 years
|
Therapy-associated morbidity
Time Frame: yearly follow up 10 years
|
grade IV toxicities
|
yearly follow up 10 years
|
Recording and evaluating the quality of therapy and diagnosis
Time Frame: 10 years
|
Recording and evaluating the quality of therapy and diagnosis
|
10 years
|
Validation of published prognostic factors at the registry cohort and the search for new possible prognostic factors
Time Frame: 10 years
|
Validation of published prognostic factors at the registry cohort and the search for new possible prognostic factors
|
10 years
|
Recording and describing new forms of therapy and new supportive measures
Time Frame: 10 years
|
Recording and describing new forms of therapy and new supportive measures
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Christoph Röllig, Prof. Dr., Universitätsklinikum Carl Gustav Carus
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kunadt D, Stasik S, Metzeler KH, Rollig C, Schliemann C, Greif PA, Spiekermann K, Rothenberg-Thurley M, Krug U, Braess J, Kramer A, Hochhaus A, Scholl S, Hilgendorf I, Brummendorf TH, Jost E, Steffen B, Bug G, Einsele H, Gorlich D, Sauerland C, Schafer-Eckart K, Krause SW, Hanel M, Hanoun M, Kaufmann M, Wormann B, Kramer M, Sockel K, Egger-Heidrich K, Herold T, Ehninger G, Burchert A, Platzbecker U, Berdel WE, Muller-Tidow C, Hiddemann W, Serve H, Stelljes M, Baldus CD, Neubauer A, Schetelig J, Thiede C, Bornhauser M, Middeke JM, Stolzel F; A. M. L. Cooperative Group (AMLCG), Study Alliance Leukemia (SAL). Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation. J Hematol Oncol. 2022 Sep 5;15(1):126. doi: 10.1186/s13045-022-01339-8.
- Hanoun M, Ruhnke L, Kramer M, Hanoun C, Schafer-Eckart K, Steffen B, Sauer T, Krause SW, Schliemann C, Mikesch JH, Kaufmann M, Hanel M, Jost E, Brummendorf TH, Fransecky L, Kraus S, Einsele H, Niemann D, Neubauer A, Kullmer J, Seggewiss-Bernhard R, Gorner M, Held G, Kaiser U, Scholl S, Hochhaus A, Reinhardt HC, Platzbecker U, Baldus CD, Muller-Tidow C, Bornhauser M, Serve H, Rollig C; Study Alliance Leukemia (SAL). Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry. J Cancer Res Clin Oncol. 2023 Jul;149(8):4611-4621. doi: 10.1007/s00432-022-04356-9. Epub 2022 Sep 28.
- Rollig C, Kramer M, Schliemann C, Mikesch JH, Steffen B, Kramer A, Noppeney R, Schafer-Eckart K, Krause SW, Hanel M, Herbst R, Kunzmann V, Einsele H, Jost E, Brummendorf TH, Scholl S, Hochhaus A, Neubauer A, Sohlbach K, Fransecky L, Kaufmann M, Niemann D, Schaich M, Frickhofen N, Kiani A, Heits F, Krumpelmann U, Kaiser U, Kullmer J, Wass M, Stolzel F, von Bonin M, Middeke JM, Thiede C, Schetelig J, Berdel WE, Ehninger G, Baldus CD, Muller-Tidow C, Platzbecker U, Serve H, Bornhauser M. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia? Blood. 2020 Aug 13;136(7):823-830. doi: 10.1182/blood.2019004583.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Estimated)
September 30, 2030
Study Completion (Estimated)
September 30, 2030
Study Registration Dates
First Submitted
March 1, 2017
First Submitted That Met QC Criteria
June 13, 2017
First Posted (Actual)
June 16, 2017
Study Record Updates
Last Update Posted (Actual)
April 18, 2024
Last Update Submitted That Met QC Criteria
April 17, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SAL-AML-REG-BIO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Myeloid Leukemia (AML)
-
Goethe UniversityCompleted
-
Daiichi Sankyo, Inc.CompletedAMLUnited States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
-
Gemin XCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingNewly Diagnosed Acute Myeloid Leukemia (AML)China
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
Zhejiang ACEA Pharmaceutical Co. Ltd.Recruiting
-
German Cancer Research CenterUniversity Hospital Heidelberg; University Hospital DresdenNot yet recruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)Germany
-
Georgetown UniversityNational Heart, Lung, and Blood Institute (NHLBI); Jazz PharmaceuticalsRecruitingAcute Myeloid Leukemia (AML) in RemissionUnited States
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
The First Affiliated Hospital of Xiamen UniversityFujian Cancer Hospital; Huizhou Municipal Central Hospital; Chipscreen Biosciences... and other collaboratorsRecruitingLeukemia, Myeloid, Acute | AML Stage, AdultChina